Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multinational Ambispective Study of the Clinical Management and Burden of Bipolar Disorder (WAVE bd Study)

NCT01062607 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01062607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01062607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multinational Ambispective Study of the Clinical Management and Burden of Bipolar Disorder (WAVE bd Study)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 30, 2010
Completion date
June 30, 2011
Enrollment
2,965 (actual)
Sites
213

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorders